Activation of the inflammatory response system: A new look at the etiopathogenesis of major depression

Neuroendocrinology Letters

Volumn 20, Issue 1-2, 1999, Pages 11-17

  Van West, Dirk ^a   Maes, Michael ^a,b,c,d,e  

^a Clinical Research Center for Mental Health of Antwerp   (Belgium)

^b IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cytokines; Depression; Psychiatry; Psychoneuroimmunology

Indexed keywords

ANTIDEPRESSANT AGENT; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 6; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TRYPTOPHAN; ZINC;

ACUTE PHASE RESPONSE; DEPRESSION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; INFLAMMATION; NEUROENDOCRINOLOGY; PSYCHOPHYSIOLOGY; REVIEW; ZINC BLOOD LEVEL;

EID: 0032753366     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Ahmed SA, Penhale WJ, Talal N (1985) Sex hormones, immune responses, and autoimmune diseases. Am J Pathol 21: 531-551
2. Anisman H, Kokkinidis L, Borowski T, Merali Z (1998) Differential effects of interleukin (IL)-1beta, IL-2 and IL-6 on responding for rewarding lateral hypothalamic stimulation. Brain Res 779: 177-187
3. Bonaccorso S, Lin A, Verkerk R, VanHunsel F, Libbrecht I, Scharpé S, DeClerck L, Stevens W, Biondi M, Janca A, Maes M (1998) Immune markers in fibromyalgia: comparison with major depressed patients and normal volunteers. J Affect Disord 48: 75-82
4. Connor TJ, Leonard BE (1998) Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci 62: 583-606
5. Cousins RJ, Leinart AS (1988) Tissue-specific regulation of zinc metabolism and metallothionein genes by interleukin-1. FASEB J 2: 2884-2890
6. Dantzer R, Bluthé RM, Laye S, Bret-Dibat JL, Parnet P, Kelley KW (1998) Cytokines and sickness behavior. Ann NY Acad Sci 840: 586-590
7. Deger O, Bekaroglu M, Orem A, Orem S, Uluutku N, Soylu C (1996) Polymorphnuclear (PMN) elastase levels in depressive disorders. Biol Psychiatry 39: 357-363
8. Frommberger UH, Bauer J, Haselbauer P, Fraulin A, Riemann D, Berger M (1997) Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Europ Arch Psychiat Clin Neurosci 247: 228-233
9. Goldblum SE, Cohen DA, Jay M, McClain CJ (1987) Interleukin 1-induced depression of iron and zinc: role of granulocytesand lactoferrin. Am J Physiol 252: 27-32
10. Hornig-Rohan M, Goodman BD, Kamoun M, Amsterdam JD (1996) Immune dysfunctions in affective subtypes. Biol Psychiatry 39: 524
11. Joyce PR, Hawes CR, Mulder RT, Sellman JD, Wilson DA, Boswell DR (1992) Elevated levels of acute phase plasma proteins in major depression. Biol Psychiatry 32: 1035-1041
12. Knapp PH, Levy EM, Giorgi RG, Black PH, Fox BH, Heeren TC (1992) Short-term immunological effects of induced emotion. Psychosom Med 54: 133-148
13. Kushner I (1982) The phenomenon of the acute phase response. Ann NY Sci 389: 39-48
14. Linthorst AC, Reul JM (1998) Brain neurotransmission during peripheral inflammation. Ann NY Acad Sci 840: 139-152
15. Maes M (1993) Acute phase protein alterations in major depression: A review. Rev Neurosci 4: 407-416
16. Maes M (1995) The Interleukin hypothesis of major depression. Prog Neuro-Psychopharmacol Biol Psychiat 19: 11-38
17. Maes M (1997) The immune pathophysiology of major depression. In: Honig A, van Praag HM (eds) Depression: Neurobiological, Psychopathological and Therapeutic Advances. John Wiley, London, pp 197-215
18. Maes M, Meltzer HY (1995) The serotonin hypothesis of major depression. In: Bloom F, Kupher D (eds) Psychopharmacology: the fourth generation of progress. Raven Press, New York, pp 933-944
19. Maes M, Smith R (1997) Immune activation and major depression: a hypothesis. Psychiat, Curr Med Lit Psychiat, Roy Soc Med 9: 3-6
20. Maes M, Smith RS (1998) Editorial: Fatty acids, cytokines and major depression. Biol Psychiat 43: 314-319
21. Maes M, Bosmans E, Suy E, Vandervorst C, Dejonckheere C, Minner B, Raus J (1991a) Depression-related disturbances in mitogen-induced lymphocyte responses, interleukin-1ß, and soluble interleukin-2-receptor production. Acta Psychiat Scand 84: 379-386
22. Maes M, Vandewoude M, Scharpé S, De Clerck L, Stevens W, Lepoutre L, Schotte C (1991b) Anthropometric and biochemical assessment of the nutritional state in depression: evidence for lower visceral protein plasma levels in depression. J Affect Disord 23: 25-33
23. Maes M, Lambrechts J, Bosmans E, Jacobs J, Suy E, Vandervorst C, De Jonckheere C, Minner B, Raus J (1992a) Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining. Psychol Med 22: 45-53
24. Maes M, Scharpé S, Bosmans E, Vandewoude M, Suy E, Uyttenbroek W, Cooreman W, Vandervorst C, Raus J (1992b) Disturbances in acute phase plasma proteins during melancholia: additional evidence for the presence of an inflammatory process during that illness. Prog Neuropsychopharmacol Biol Psychiat 16: 501-515
25. Maes M, Scharpé S, Van Grootel L, Uyttenbroeck W, Cooreman W, Cosyns P, Suy E (1992c) Higher α1-antitrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: further evidence for the existence of an inflammatory response during that illness. J Affect Disord 24 183-192
26. Maes M, Bosmans E, Meltzer HY, Scharpe S, Suy E (1993a) Interleukin-1ß: A putative mediator of HPA-axis hyperactivity in major depression? Am J Psychiat 150: 1189-1193
27. Maes M, Meltzer HY, Scharpé S, Uyttenbroeck W, Cooremans W, Suy E (1993b) Psychomotor retardation, anorexia, weight loss, sleep disturbances and loss of energy: psychopathological correlates of hyperhaptoglobinemia during major depression. Psychiat Res 47: 229-241
28. Maes M, Scharpé S, Meltzer HY, Bosmans E, Suy E, Minner B, Calabrese J, Uyttenbroeck W, Vandervorst C, Raus J, Cosyns P (1993c) Relationships between interleukin-6 activity, acute phase proteins and HPA-axis function in severe depression. Psychiat Res 49: 11-27
29. Maes M, Scharpé S, Meltzer HY, Cosyns P (1993d) Relationships between increased haptoglobin plasma levels and activity of cell-mediated immunity. Biol Psychiat 34: 690-701
30. Maes M, De Langhe J, Scharpé S, Meltzer HY, Cosyns P, Suy E, Bosmans E (1994a) Haptoglobin phenotypes and gene frequencies in unipolar major depression. Am J Psychiat 151: 112-116
31. Maes M, Scharpe S, Cosyns P, Meltzer HY (1994b) Relationships between basal hypothalamic-pituitary-thyroid axis activity and plasma haptoglobin levels in depression. J Psychiat Res 28: 123-134
32. Maes M, Scharpe S, D'Haese W, De Broe M, Cosyns P (1994c) Hypozincaemia in depression. J Affect Disord 31: 135-140
33. Maes M, Scharpe S, Meltzer HY, Okayli G, D'Hondt P, Cosyns P (1994d) Increased neopterin and interferon gamma secretion and lower L-tryptophan levels in major depression: further evidence for immune activation in severe depression. Psychiat Res 54: 143-160
34. Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R, Desnyder R (1995a) Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 34: 301-309
35. Maes M, Scharpe S, Neels H, Wauters A, Van Gastel A, Cosyns P (1995b) Total serum protein and serum protein fractions in major depression. J Affect Disord 34: 61-69
36. Maes M, Smith R, Christophe A, Cosyns P, Desnyder R, Meltzer HY (1996a) Fatty acid composition in major depression: decreased ω3 fractions in cholesteryl esters and increased C20:4ω6/C20:5ω3 ratio in cholesteryl esters and phospholipids. J Affect Disord 38: 35-46
37. Maes M, Van de Vyvere J, Vandoolaeghe E, Bril T, Demedts P, Wauters A, Neels H (1996b) Alterations in iron metabolism and the erythron in major depression: further evidence for a chronic inflammatory process. J Affect Disord 40: 23-33
38. Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H (1997a) Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 9: 853-858
39. Maes M, Delanghe J, Ranjan R, Meltzer HY, Desnyder R, Cooreman W, Scharpe S (1997b) The acute phase protein response in schizophrenia, mania and major depression: effects of psychotropic drugs. Psychiat Res 66: 1-11
40. Maes M, Vandoolaeghe E, Neels H, Demedts P, Wauters A, Meltzer HY, Altamura C, Desnyder R (1997c) Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. Biol Psychiat 42: 349-358
41. Maes M, Verkerk R, Vandoolaeghe E, Van Hurisel F, Neels H, Wauters A, Demedts P, Scharpe S (1997d) Serotonin-immune interactions in major depression: lower serum tryptophan as a marker of an immune-inflammatory response. Eur Arch Gen Psychiat Clin Neurosci 247: 154-161
42. Maes M, Song C, Lin A, Bonaccorso S, Scharpe S, Kenis G, DeJongh R, Bosmans E, Scharpe S (1998a) Negative immunoregulatory effects of antidepressants: increased production of interleukin-10 and suppressed production of interferon-gamma. Neuropsychopharmacol, accepted
43. Maes M, Song C, Lin A, DeJongh R, Kenis G, Bosmans E, DeMeester I, Neels H, Scharpe S (1998b) Immune and clinical correlates of psychological stress-induced production of interferon-γ and IL-10 in humans. In: Plotnikoff NP, Faith RE, Murgo AJ, Good RA (eds) Cytokines, Stress and Immunity. Boca Raton: CRC-Press, pp 39-50
44. Maes M, Song C, Lin A, Gabriels L, DeJongh R, Van Gastel A, Kenis G, Bosmans E, DeMeester I, Benoyt I, Neels H, Demedts P, Janca A, Scharpe S, Smith RS (1998c) The effects of psychological stress on humans: increased production of proinflammatory cytokines and a Th-1-like response in stress-induced anxiety. Cytokine 10: 313-318
45. Maier SF, Watkins LR (1995) Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock. Brain Res 695: 279-282
46. Maier SF, Watkins LR (1998) Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev 105: 83-107
47. Miller AH, Lackner C (1989) Tricyclic antidepressants and immunity. In: Miller H (ed) Depressive Disorders and Immunity. American Psychiatric Press, Washington DC, pp 85-104
48. Miller AH, Spencer RL, Pearce BD, Pisell TL, Tanapat P, Leung JJ, Dhabhar FS, McEwen BS, Biron CA (1997) 1996 Curt P. Richter Award. Effects of viral infection on corticosterone secretion and glucocorticoid receptor binding in immune tissues. Psychoneuroendocrinol 22: 455-474
49. Navarra P, Tsagarakis S, Faria MS, Rees LH, Besser GM, Grossman AB (1991) Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone 41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. Endocrinol 128: 37-44
50. Sapolsky R, Rivier C, Yamamoto G (1987) Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Sci 238: 522-524
51. Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A, Kirchner H (1996) Major depressive disorder is associated with elevated monocyte counts. Acta Psychiat Scand 94: 198-204
52. Sluzewska A, Rybakowski JK, Laciak M, Mackiewicz A, Sobieska M, Wiktorowiz K (1995) Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann NY Acad Sci 762: 474-6
53. Sluzewska A, Rybakowski J, Bosmans E, Sobieska M, Berghmans R, Maes M, Wiktorowicz K (1996a) Indicators of immune activation in major depression. Psychiat Res 64:161-167
54. Sluzewska A, Rybakowski J, Sobieska M, Wiktorowicz K (1996b) Concentration and microheterogenecity forms of alpha-1-acid glycoprotein in major depressed disorder. J Affect Disord
55. Solomons NW (1988) Zinc and copper. In: Shils ME and Youg VR (eds) Modern Nutrition in Health and Disease. Lea and Febiger, Philadelphia, pp 238-262
56. Song C, Dinan T, Leonard BE (1994) Changes in immuno-globulin, complement and acute phase protein levels in the depressed patients and normal controls. J Affect Disord 30: 283-288
57. Song C, Lin A, Bonaccorso S, Heide C, Verkerk R, Kenis G, Bosmans E, Scharpe S, Cosyns P, DeJong R, Maes M (1998) The inflammatory response system and the availability of tryptophan to the brain of patients with major depression and sleep disorders. J Affect Disord 49: 211-219
58. Swartz CM (1990) Albumin decrement in depression and cholesterol decrement in mania. J Affect Disord 19: 173-176
59. Vandoolaeghe E, DeVos N, DeSchouwer P, Neels H, Maes M. (1999) Lower number of red blood cells, hematocrit and hemoglobin in major depression: effects of antidepressants. Hum Psychopharmacol, accepted
60. Washburn TC, Medearis J, Childs B (1965) Sex differences in susceptibility to infections. Ped 35: 57-64
61. Xia Z, DePierre JW, Nassberger L (1996) Tricyclic antidepressants inhibit IL-6, IL-1ß and TNF-α release in human blood monocytes and IL-2 and interferon-γ in T cells. Immunopharmacol 34: 27-37